SciELO - Scientific Electronic Library Online

SciELO - Scientific Electronic Library Online

Article References

ALVIS-GUZMAN, Nelson; PATERNINA-CAICEDO, Angel; ALVIS-ESTRADA, Luis  and  DE LA HOZ-RESTREPO, Fernando. Costos directos de varicela complicada en una población pediátrica de Colombia. Rev. salud pública [online]. 2011, vol.13, n.6, pp. 921-929. ISSN 0124-0064.  http://dx.doi.org/10.1590/S0124-00642011000600005.

    1. Espinal CA, Upegu G, Cristancho LM. Indicadores epidemiológicos de varicela en Colombia. Infectio. 1998;2(2):77-85. [ Links ]

    2. Nicolosi A, Sturkenboom M, Mannino S, Arpinelli F, Cantarutti L, Giaquinto C. The incidence of varicella: correction of a common error. Epidemiology. 2003 Jan;14(1):99-102. [ Links ]

    3. Saez-Llorens X, De Suman O, De Moros D, Rubio Mdel P. Complications and costs associated with chickenpox in immunocompetent children. Rev Panam Salud Publica. 2002 Aug;12(2):111-6. [ Links ]

    4. DANE. Indices de Precios al Consumidor.1996- 2011 [Internet].  Bogotá D.C.: Departamento Administrativo Nacional de Estadística; 2009; Available from: http://www.dane.gov.co/files/investigaciones/ipc/ene11/IPC_Variacion.xls. Consulted Enero 3, 2009. [ Links ]

    5. Law B, Fitzsimon C, Ford-Jones L, McCormick J, Riviere M. Cost of chickenpox in Canada: part II. Cost of complicated cases and total economic impact. The Immunization Monitoring Program-Active (IMPACT). Pediatrics. 1999 Jul;104(1 Pt 1):7-14. [ Links ]

    6. Law B, Fitzsimon C, Ford-Jones L, MacDonald N, Dery P, Vaudry W, et al. Cost of chickenpox in Canada: part I. Cost of uncomplicated cases. Pediatrics. 1999 Jul;104(1 Pt 1):1-6. [ Links ]

    7. Giacchino R, Losurdo G, Castagnola E. Decline in mortality with varicella vaccination. N Engl J Med. 2005 Apr 28;352(17):1819. [ Links ]

    8. Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005 Feb 3;352(5):450-8. [ Links ]

    9. Gil A, Oyaguez I, Carrasco P, Gonzalez A. Epidemiology of primary varicella hospitalizations in Spain. Vaccine. 2001 Nov 12;20(3-4):295-8. [ Links ]

    10. Alonso J, Lozano de la Torre M, Madrigal V. Vacuna antivaricela: ¿llegó el momento de su inclusión en el calendario vacunal español? Bol Pediatr. 1999;39:229-35. [ Links ]

    11. Pena-Rey I, Perez-Farinos N, Cortes-Garcia M, Amela-Heras C. Coste-efectividad de la vacunacion contra la varicela en adolescentes en Espana. Gac Sanit. 2004 Jul-Aug;18(4):287-94. [ Links ]

    12. Lenne X, Diez Domingo J, Gil A, Ridao M, Lluch JA, Dervaux B. Economic evaluation of varicella vaccination in Spain: results from a dynamic model. Vaccine. 2006 Nov 17;24(47-48):6980-9. [ Links ]

    13. Diez Domingo J, Ridao M, Latour J, Ballester A, Morant A. A cost benefit analysis of routine varicella vaccination in Spain. Vaccine. 1999 Mar 17;17(11-12):1306-11. [ Links ]

    14. Coudeville L, Brunot A, Giaquinto C, Lucioni C, Dervaux B. Varicella vaccination in Italy : an economic evaluation of different scenarios. Pharmacoeconomics. 2004;22(13):839-55. [ Links ]

    15. Coudeville L, Brunot A, Szucs TD, Dervaux B. The economic value of childhood varicella vaccination in France and Germany. Value Health. 2005 May-Jun;8(3):209-22. [ Links ]